March 30 (Reuters) - Argenica Therapeutics Ltd (AGN) :
- ARGENICA THERAPEUTICS LTD - POSITIVE PRECLINCAL DATA ON EFFICACY OF ARG-007 IN NEW INDICATION - GLOBAL CEREBRAL ISCHAEMIA
- ARGENICA THERAPEUTICS LTD - RESULTS FROM THE STUDY WILL FURTHER SUPPORT EFFICACY DATA PACKAGE FOR PHASE 1 CLINICAL TRIAL.
News: AGN Argenica Therapeutics Says Positive Preclincal Data On Efficacy Of Arg-007 In New...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
72.0¢ |
Change
0.030(4.35%) |
Mkt cap ! $92.22M | |||
| Open | High | Low | Value | Volume |
| 70.0¢ | 72.5¢ | 70.0¢ | $43.97K | 62.35K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17447 | 72.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 72.5¢ | 4200 | 1 |
View Market Depth
| Last trade - 14.49pm 04/10/2024 (20 minute delay) ? |
| AGN (ASX) Chart |